Advertisement

Topics

Biomarkers Needed to Refine Use of Novel Combos in mRCC

10:41 EDT 17 Apr 2019 | OncLive

Neeraj Agarwal, MD, discusses the recent encouraging data reported in mRCC and highlighted the next steps needed to move the needle forward in this space.

Original Article: Biomarkers Needed to Refine Use of Novel Combos in mRCC

NEXT ARTICLE

More From BioPortfolio on "Biomarkers Needed to Refine Use of Novel Combos in mRCC"

Advertisement
Quick Search
Advertisement
Advertisement